The impact of H. pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota

被引：0
|
作者：
Cui, Mengyan [1 ]
Cui, Zhenyu [1 ]
Zhao, Mengqi [1 ]
Zhang, Mengjie [1 ]
Jiang, Qiaoli [1 ]
Wang, Jingjing [1 ]
Lu, Lungen [1 ]
Lu, Yingying [1 ]
机构：
[1] Shanghai Gen Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
intrahepatic cholangiocarcinoma; older adults; prognosis; propensity score matching; risk factor;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
0168
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [1] The impact of H. pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
    Cui, Mengyan
    Cui, Zhenyu
    Zhao, Mengqi
    Zhang, Mengjie
    Jiang, Qiaoli
    Wang, Jingjing
    Lu, Lungen
    Lu, Yingying
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 50 - 50
  • [2] The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
    Cui, Meng-Yan
    Cui, Zhen-Yu
    Zhao, Meng-Qi
    Zhang, Meng-Jie
    Jiang, Qiao-Li
    Wang, Jing-Jing
    Lu, Lun-Gen
    Lu, Ying-Ying
    [J]. BMC MICROBIOLOGY, 2022, 22 (01)
  • [3] The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
    Meng-Yan Cui
    Zhen-Yu Cui
    Meng-Qi Zhao
    Meng-Jie Zhang
    Qiao-Li Jiang
    Jing-Jing Wang
    Lun-Gen Lu
    Ying-Ying Lu
    [J]. BMC Microbiology, 22
  • [4] Eradication of H. pylori Infection in Patients Allergic to Penicillin Using Triple Therapy with a PPI, Metronidazole and Sitafloxacin
    Furuta, Takahisa
    Sugimoto, Mitsushige
    Yamade, Mihoko
    Uotani, Takahiro
    Sahara, Shu
    Ichikawa, Hitomi
    Kagami, Takuma
    Yamada, Takanori
    Osawa, Satoshi
    Sugimoto, Ken
    Watanabe, Hiroshi
    Umemura, Kazuo
    [J]. INTERNAL MEDICINE, 2014, 53 (06) : 571 - 575
  • [5] H. pylori Eradication Therapy
    Hsu, Ping-I
    Peng, Nan-Jing
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2013, 2013
  • [6] The Trend of Eradication Rates of First-Line Therapy and Second-Line Quadruple Therapy Containing Metronidazole for H. pylori Infection for Recent Five Years
    Park, J.
    Park, S.
    Kim, G.
    Seoul, S.
    Moon, J.
    Jee, S.
    Jung, H.
    Lee, D.
    Kim, J.
    Lee, S.
    [J]. HELICOBACTER, 2009, 14 (04) : 400 - 400
  • [7] Gastric cancers of the diffuse and intestinal types and MALT lymphomas after eradication therapy for H. pylori infection
    Kosunen, T. U.
    Pukkala, E.
    Sarna, S.
    Rautelin, H.
    [J]. HELICOBACTER, 2008, 13 (05) : 475 - 475
  • [8] The exposure of antibiotics on the eradication of bismuth quadruple therapy in H. pylori infection
    聂尚姝
    [J]. China Medical Abstracts (Internal Medicine), 2022, (01) : 47 - 48
  • [9] THE INFLUENCE OF HELICOBACTER PYLORI ERADICATION THERAPY ON INTESTINAL MICROBIOTA
    Safina, Dilyara
    Abdulkhakov, Sayar
    Grigoryeva, Tatyana
    Khusnutdinova, Dilyara
    Kovarsky, Boris
    Tyakht, Alexander
    Markelova, Maria
    Boulygina, Eugenia A.
    Siniagina, Maria
    Malanin, Sergey
    Abdulkhakov, Rustem
    Chernov, Vladislav
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S633 - S633
  • [10] Preoperative H. pylori eradication therapy facilitates precise delineation in early gastric cancer with current H. pylori infection
    Yan, Zhiyu
    Zou, Long
    Wang, Qiang
    Zhang, Shengyu
    Jiao, Yuhao
    Xiong, Dingkun
    Jiang, Qingwei
    Guo, Tao
    Feng, Yunlu
    Wu, Dongsheng
    Lai, Yamin
    Yan, Xuemin
    Xu, Tao
    Fang, Weigang
    Wu, Xi
    Zhou, Weixun
    Yang, Aiming
    [J]. DIGESTIVE DISEASES, 2024, 42 (01) : 1 - 11
12345